Clinical meaning of JAK2 V617F mutation in chronic myeloproliferative disorders – the first experience

Clinical meaning of JAK2 V617F mutation in chronic myeloproliferative disorders – the first experience

<p>Background An acquired V617F mutation in the JAK2 gene was found to occur in most patients with polycythaemia vera (PV), and about a half of those with essential thrombocythaemia (ET) and chronic idiopathic myelofibrosis (CIMF). It is the first clonal marker that allows differentiation betw...

Full description

Bibliographic Details
Main Authors: Joško Vučković, Tadej Pajič, Rajko Kušec, Mateja Grat, Marjan Lorbek, Dinko Rogulj, Rok Pavlič, Ivan Žuran
Format: Article
Language:English
Published: Slovenian Medical Association 2006-10-01
Series:Zdravniški Vestnik
Subjects:
chronic myeloproliferative disorders
essential thrombocythaemia
polycythaemia vera
idiophatic myelofibrosis
V617F mutation of JAK2
Online Access:http://vestnik.szd.si/index.php/ZdravVest/article/view/2034

Similar Items

Similar Items